Wyeth: willing and able to do deals

[Joelle]

Wyeth: willing and able to do deals
      

Pharmaceutical company Wyeth’s strong cash position could allow it to make new biotech acquisitions even as works to fend off competition from generic drugmakers for several of its biggest products.
Wyeth Chief Executive Bernard Poussot, speaking on Wednesday at a Goldman Sachs health-care meeting, noted that many of the company’s top-selling products are biotech medicines — [...]
         

You are not allowed to view links. Register or Login